To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

IDEF 2021: Roketsan pursues parallel development of heavy and lightweight torpedoes

23rd August 2021 - 12:30 GMT | by Tayfun Özberk in Istanbul

RSS

Roketsan has applied lesson from developing AKYA (in the foreground) to the ORKA (top right) programme. (Photo: author)

The AKYA heavy torpedo has undergone firing trials and will equip Turkish submarines, while Roketsan's developmental ORKA has surface- and air-launched applications.

Turkish missile manufacturer Roketsan showcased its AKYA heavy and ORKA lightweight torpedoes at IDEF 2021.

Murat Ikinci, CEO of Roketsan, revealed during a news conference on August 16 that AKYA will be the Type 209 submarine's primary weapon once it enters service. 'The firing trials of AKYA are still going on. We will deliver the first version of AKYA to the Turkish Armed Forces before the end of the year,' he said, adding that the ORKA lightweight torpedo could be be launched from air assets as well as surface combatants.

On January 25, the Turkish Navy fired AKYA for the first

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 1 free story per week
  • Personalised news alerts
  • Daily and weekly newsletters
  • Free magazine subscription to all our titles
  • Downloadable equipment data handbooks
  • Distribution rights (Corporate only)
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
  • 10-year news archive access
  • Downloadable equipment data handbooks
  • Distribution rights (Corporate only)
Start your free trial

Share to

Linkedin